Company / Revenue
BIOMERICA INC Revenue History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$5.3M
FY2024
5-year range
$5.3M / $18.9M
FY2020-FY2024
Trend
-1.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 9 years, ranging from $5M in FY2019 to $19M in FY2021.
Based on SEC 10-K filings.
$5M in FY2024 with a 5-year CAGR of +0.4%.
Remained stable around $5M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -34.5%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2024, revenue decreased 1.9% year-over-year.
- Peak revenue was recorded in FY2021.
- Lowest revenue in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $5.3M | -1.9% |
| FY2023 | $5.4M | +1.4% |
| FY2022 | $5.3M | -71.7% |
| FY2021 | $18.9M | +162.1% |
| FY2020 | $7.2M | +38.4% |
| FY2019 | $5.2M | +0.0% |
| FY2018 | $5.2M | -6.5% |
| FY2017 | $5.6M | -3.9% |
| FY2016 | $5.8M | +12.7% |
As of FY2024 · SEC Form 10-K · Last checked Jun 22, 2026